ey0016.5-2 | New Therapies and Novel Therapeutic Strategies | ESPEYB16
F Zaman
, Y Zhao
, B Celvin
, HH Mehta
, J Wan
, D Chrysis
, C Ohlsson
, B Fadeel
, P Cohen
, L Savendahl
Abstract: FASEB J. 2019;33:49624974.In brief: Glucocorticoid-induced growth impairment is reverted by the mitochondrial peptide humanin in dexamethasone-treated mice without attenuation of anti-inflammatory effects.Comment: Humanin (HN) is a 24 aminoacid peptide that was originally discovered as a neuroprotective factor and later shown ...